Status:
COMPLETED
Study to Determine if the Midazolam-Meperidine-Dexmedetomidine is Superior to the Midazolam-Meperidine for Sedation During ERCP
Lead Sponsor:
Seoul National University Hospital
Collaborating Sponsors:
Hana Pharm Co., Ltd.
Conditions:
Undergoing ERCP for Diagnostic or Therapeutic Purposes
Eligibility:
All Genders
20-80 years
Phase:
PHASE4
Brief Summary
Endoscopic retrograde cholangiopancreatography (ERCP) takes a longer time and is more complex to perform than the other parallel procedures, causing discomfort to patients. It is commonly performed un...
Detailed Description
Compared with upper gastrointestinal endoscopy, endoscopic retrograde cholangiopancreatography (ERCP) takes a longer time to perform and causes more discomfort to patients. In ERCP, benzodiazepine alo...
Eligibility Criteria
Inclusion
- Those who are admitted for diagnostic and therapeutic ERCPs
- aged 20 to 80 years
- American Society of Anesthesiologists (ASA) classification I to III
Exclusion
- ASA physical status IV and V
- allergic to any components of sedation and opioid drugs
- patients with chronic illicit drug use
Key Trial Info
Start Date :
August 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2012
Estimated Enrollment :
110 Patients enrolled
Trial Details
Trial ID
NCT01404689
Start Date
August 1 2011
End Date
March 1 2012
Last Update
July 16 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Division of Gastroenterology, Department of Internal Medicine, Seoul National University Bundang Hospital
Seongnam-si, Gyeonggi-do, South Korea, 463-707